Mary-Helen Binger

Title: Mary-Helen Binger: Innovator in Immunogenic Polypeptides

Introduction

Mary-Helen Binger is a notable inventor based in Hopewell, NJ (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines against Eimeria parasites. With a total of 4 patents, her work has been instrumental in advancing the understanding and treatment of coccidiosis.

Latest Patents

Among her latest patents, one focuses on DNA encoding Eimeria antigen. This invention provides an immunogenic polypeptide with a specific amino acid sequence that is capable of inducing an immune response against Eimeria parasites. Additionally, her work includes the development of coccidiosis vaccines that comprise these polypeptides, as well as the DNA encoding such polypeptides, recombinant vectors, and transformed microorganisms containing these innovations.

Career Highlights

Mary-Helen Binger has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and Roche Vitamins Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Mary-Helen has collaborated with notable colleagues such as Luis Pasamontes and Richard Anthony Chizzonite. These partnerships have further enriched her work and expanded the impact of her inventions.

Conclusion

Mary-Helen Binger's innovative contributions to immunology and vaccine development highlight her as a key figure in the fight against Eimeria parasites. Her patents and collaborations reflect her dedication to advancing scientific knowledge and improving public health.